ABOS Stock Analysis: Buy, Sell, or Hold?

ABOS - Acumen Pharmaceuticals, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$2.23
0.06 (2.53%) β–²
5d: -15.4%
30d: -2.84%
90d: -17.29%
WAIT
LOW Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 11, 2026 24d

Get Alerted When ABOS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ABOS is down 15.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: ABOS is currently trading at $2.23, which is considered slightly low relative to its 30-day fair value range of $2.26 to $2.64.

Technical Outlook: Technically, ABOS is in a strong downtrend. Immediate support is located at $2.09, while resistance sits at $2.78.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.40 (+241.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $2.26 - $2.64
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.6%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 241.0% below Wall St target ($7.40)
  • WARNING: Recommendation downgraded due to -15.4% 5-day decline - wait for stabilization

Trading Range Analysis

30-Day Trading Range $2.26 - $2.64
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $2.09
Resistance Level $2.78
Current Trend Strong Downtrend
Technical data as of Jul 17, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.44
Wall Street Target $7.40 (+241.0%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 17, 2026 3:27 PM ET
Data refreshes hourly during market hours. Next update: 4:27 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Siemers SELL 895 shares 2026-01-22
Matt Zuga SELL 1687 shares 2026-01-22
Russell Barton SELL 462 shares 2026-01-22

Unlock Insider Activity

See real-time buying/selling by company executives for ABOS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$26 47 HOLD
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$822 66 BUY
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1051 51 HOLD
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$258 64 BUY
DYN
Dyne TherapeuticsΒ Inc
STRONG BUY
14 analysts
$38 57 HOLD

More Analysis for ABOS

ABOS Technical Chart ABOS Price Prediction ABOS Earnings Date ABOS Investment Advisor ABOS Fair Price Analyzer ABOS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals